nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator
What happened when an LJI scientist revisited a diabetes mystery
No one knows exactly what triggers type 1 diabetes, but researchers at La Jolla Institute for Immunology have uncovered some fascinating clues.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
LA JOLLA—Your pancreas is studded with cell clusters called islets. In most people, special beta cells live snug in the
LA JOLLA—Your pancreas is a little sweet potato-shaped organ that sits snug behind your stomach. The pancreas is studded with
Team: Mehdi Benkahla It is thought that an interaction between predisposing genes and environmental factors, such as viral infections, may
Team: Mehdi Benkahla and Somayeh Sabouri Type 1 diabetes (T1D) is an autoimmune disease characterized by increased blood glucose levels
Team: Sakthi Rajendran, Estefania Quesada-Masachs, Christine Bender Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of
Team: Sakthi Rajendran, Estefania Quesada-Masachs and Mehdi Benkahla IL-17 is a pro-inflammatory cytokine important in shaping host immune responses against
Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing β cells are attacked
Team: Estefania Quesada-Masachs, Sakthi Rajendran Type 1 diabetes (T1D), an autoimmune disease that usually affects young people, is on the